{
    "Trade/Device Name(s)": [
        "Idylla Respiratory (IFV-RSV) Panel",
        "IdyllaTM Respiratory (IFV-RSV) Panel"
    ],
    "Submitter Information": "Janssen Diagnostics, a division of Janssen Pharmaceutica NV",
    "510(k) Number": "K163628",
    "Predicate Device Reference 510(k) Number(s)": [
        "K103209"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "OCC"
    ],
    "Summary Letter Date": "July 26, 2017",
    "Summary Letter Received Date": "July 28, 2017",
    "Submission Date": "July 10, 2017",
    "Regulation Number(s)": [
        "21 CFR 866.3980"
    ],
    "Regulation Name(s)": [
        "Respiratory viral panel multiplex nucleic acid assay"
    ],
    "Analyte Class(es)": [
        "virology",
        "genetic molecular"
    ],
    "Analyte(s)": [
        "Influenza A",
        "Influenza A subtype H1",
        "Influenza A subtype H3",
        "Influenza A subtype 2009 H1",
        "H275Y mutation of Influenza A subtype 2009 H1",
        "Influenza B",
        "Respiratory Syncytial Virus (A and B)"
    ],
    "Specimen Type(s)": [
        "Nasopharyngeal swabs"
    ],
    "Specimen Container(s)": [
        "Viral transport media"
    ],
    "Instrument(s)/Platform(s)": [
        "Idylla System"
    ],
    "Method(s)/Technology(ies)": [
        "Reverse transcription PCR (RT-PCR)",
        "Multiplex PCR",
        "Automated sample preparation"
    ],
    "Methodologies": [
        "Qualitative nucleic acid amplification",
        "Real-time PCR",
        "Fluorescent probe detection"
    ],
    "Submission Type(s)": [
        "Panel",
        "Assay",
        "Cartridge"
    ],
    "Document Summary": "FDA 510(k) summary for Idylla Respiratory (IFV-RSV) Panel, a molecular in vitro diagnostic for detection of influenza and RSV from nasopharyngeal swabs using automated RT-PCR on the Idylla system",
    "Indications for Use Summary": "Qualitative detection of nucleic acids for Influenza A (and subtypes), Influenza B, and Respiratory Syncytial Virus (A and B) from nasopharyngeal swabs in viral transport media of adult and pediatric patients to aid in diagnosis of respiratory viral infection, used in conjunction with clinical and laboratory findings.",
    "fda_folder": "Microbiology"
}